Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
37 Because intense exercise can temporarily deplete glutathione, maintaining higher levels may support recovery and help counter oxidative stress
Regular follow-up is essential for monitoring treatment effectiveness and adjusting the injection schedule if needed
More importantly, these results were not replicated in further studies
